Surveillance of measles in Germany

In Germany, as in the entire WHO Region Europe, the goal has been set to el iminate measles by the year 2007. In order to achieve this, high vaccinatio n rates of greater than or equal to 95% are necessary as well as an intensi ve surveillance consisting of a continuous record of the age and region-spe cific incidence, vaccination rates and the seroprevalence. Data on the vacc ination status, recorded in the districts at the time of school entry, are collected centrally and evaluated at the RKI since 1998. The vaccination ra te for the 1(st) dose against measles is on the average 84.6 % and for the 2(nd) dose 14.3%. A nationwide sentinel established in 1999 with over 1200 medical practitioners permits an estimate of the countrywide measles incide nce on the basis of the registered measles cases. Results from the year 200 0 showed a very big difference between the old Federal States (mean inciden ce of 46.8 illness per 100 000) and the new Federal States (0.9 per 100 000 ). Most of those falling sick were unvaccinated (85.4%), where 35% refused the vaccination. Thirty-nine percent of the cases were examined in the labo ratory and from these 58% were clinically confirmed; 10% of the cases occur red in those receiving one dose of vaccine and none in those receiving 2 do ses. The age peak of the sick children was between 1 to 4 years of age. Mea sles notification is obligatory in Germany since January 2001. From these d ata, the incidence of the 1(st) quarter has been calculated. it varies wide ly depending on the State (e.g. Bavaria 5.7 / 100.000 vs < 0.5 % in new Fed eral States). The seroprevalance studies conducted in 1993 and in 1995/96 s how large gaps in immunity of small children and suggests that the MMR vacc ination may have been carried out too late. The elimination of measles in G ermany can only be achieved if the vaccination rates are increased and the 1(st) MMR vaccination is performed as early as possible. In particular, the vaccination rates for the 2nd dose are inadequate to be able to reach thos e with vaccine failures in a greater proportion and to close the gaps of va ccination.